|
Volumn 33, Issue 1-2, 2001, Pages 1015-1017
|
Induction therapy with daclizumab as part of the immunosuppressive regimen in human small bowel and multiorgan transplants
a c d c a b a b a c d c a |
Author keywords
[No Author keywords available]
|
Indexed keywords
INTERLEUKIN 2 RECEPTOR ANTIBODY;
METHYLPREDNISOLONE;
OKT 3;
TACROLIMUS;
ADULT;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE TRANSPLANTATION;
MALE;
ORGAN TRANSPLANTATION;
PRIORITY JOURNAL;
ADULT;
ANTIBODIES, MONOCLONAL;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GRAFT REJECTION;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINE, SMALL;
MALE;
ORGAN TRANSPLANTATION;
REMISSION INDUCTION;
|
EID: 0035086687
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(00)02310-1 Document Type: Conference Paper |
Times cited : (21)
|
References (10)
|